Answers are grounded in this paper and cite their sources.
for additional doses of vaccine to people in the risk group.On the control breast USG performed on 27.08.2021;no recurrent mass and pathological LAP were observed.A second dose of Biontech was performed 3 months later and LAP did not develop.Routine follow-up continues.
No takes yet. Share an insight, caveat, or question.
Elif Şahin (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: